| payload |
{"artifact_id":"artf_thesis_4ca5ad69cf {"artifact_id":"artf_thesis_4ca5ad69cf951b99","evidence_event_ids":["evt_b3fe7faacddb","evt_bde00d9a6e6f","evt_e32901815d25","evt_84de6646dcd8","evt_16243982273d"],"kind":"opportunity_thesis","meta":{"confidence":0.4138,"lane":"monitor","morning_holdback":false,"rank_score":0.4138,"theme_keys":[],"urgency_reason":"not_urgent","urgent":false},"output_json":{"artifact_kind_detail":"research_thesis","catalysts":[],"confidence":0.4138,"decision_reason_codes":["research_thesis"],"headline":"TeraWulf\u2019s April 2026 public offering closed on April 16, 2026, selling 47,400,000 shares of common stock at $19.00 per share and generating approximately $1,004.3 million in net proceeds (after underwriting discounts/commissions and est...","investigation_questions":["The filing\u2019s SEC \u201cItem\u201d section(s) and exhibit list beyond Exhibit 1.1 and Exhibit 99.1 / Exhibit 5.1 are not explicitly enumerated in th...","The filing date shown in the structured context (2026-04-17T02:13:18.114675+00:00) is not directly stated in the article text; the articl...","The provided text does not clearly show the exact number of performance stock units disposed vs remaining (the text includes numeric frag...","The exact grant date of the performance stock units is not explicitly stated in the provided excerpt (only the vesting window reference t..."],"portfolio_fit":{"applied":false,"boost":0.0,"exit_risk_flagged":false,"hedge_suggested":null,"matched_holdings":[],"matched_watchlist":[],"stub_version":"v1","why_you":""},"related_tickers":["WULF"],"risk_level":"medium","theme_keys":[],"thesis":"Form 8-K \u00b7 TERAWULF INC. \u00b7 Filed 20260416; On April 14, 2026, TeraWulf entered into an underwriting agreement with Morgan Stanley & Co. LLC to sell 47,400,000 shares of its common stock at a public offering price of $19....; The underwriting agreement granted a 30-day option for up to an additional 7,110,000 shares (optional shares). \u2014 Signal convergence: WULF filed 424B5 [neutral]"},"ready_at":"2026-04-17T03:46:55.829000+00:00","status":"ready","summary":"Form 8-K \u00b7 TERAWULF INC. \u00b7 Filed 20260416; On April 14, 2026, TeraWulf entered into an underwriting agreement with Morgan Stanley & Co. LLC to sell 47,400,000 shares of its common stock at a public offering price of $19....; The underwriting agreement granted a 30-day option for up to an additional 7,110,000 shares (optional shares). \u2014 Signal convergence: WU","title":"[THESIS] WULF \u2014 TeraWulf\u2019s April 2026 public offering closed on April 16, 2026, selling 47,400,000 shares of common stock at $19.00 per share and generating approximately $1,004.3 million in net proce","updated_at":"2026-04-17T03:46:55.829000+00:00"}... |